Pioglitazone use and risk of bladder cancer: a systematic literature review and meta-analysis of observational studies.
Juha MehtäläHoussem KhanfirDimitri BennettYizhou YePasi KorhonenFabian HotiPublished in: Diabetology international (2018)
In line with previous meta-analyses, we observed a small but statistically significant association between ever (vs. never) use of pioglitazone and bladder cancer risk; however, causality is not established and alternative explanations cannot be ruled out.